Imprimis Pharmaceuticals, Inc.
Planned ASCRS Symposium events and sessions will highlight Imprimis’ Dropless Therapy and Combination Drop Therapy
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced its attendance, physician presentations, and related events at the 2015 American Society of Cataract and Refractive Surgery (ASCRS) in San Diego, CA, April 17-21.
Imprimis will host an informational Go Dropless™and LessDrops™Reception on Saturday, April 18, 5:30-8:30 pm at the Hard Rock Hotel. Mark L. Baum, CEO of Imprimis Pharmaceuticals, will convey the company's vision and the continuing success stemming from the Go Dropless campaign launched in April 2014 and recent launch of the LessDropscampaign. Additionally, a panel of current prescribers will share their experience and expertise with the proprietary formulations and how they have incorporated them into their surgical practices. The faculty members will include: Ephraim Atwal, MD (Cheektowaga, NY), Bret Fisher, MD (Panama City, FL), Damien Goldberg, MD (Torrance, CA), Tyrie Jenkins, MD, (Honolulu, HI), Jeffrey Liegner, MD (Sparta, NJ), James Loden, MD (Goodlettsville, TN), Ahad Mahootchi, MD (Zephyrhills, FL), Sydney Tyson, MD (Vineland, NJ), and William Wiley, MD (Avon, OH).
Mark L. Baum, CEO of Imprimis stated, “It is a privilege to participate at the ASCRS Symposium and Congress taking place in our home town of San Diego. Interest in our innovative ophthalmic drug formulations continues to grow and we look forward to visiting with and hosting our friends and customers in the ophthalmology community. This venue also provides us with the opportunity to share the experience of our Dropless Therapy injectable and Combination Drop Therapy topical formations with new physicians and their staffs who have not yet heard our message.”
Dropless Therapy will be presented at ASCRS in several sessions:
- Sunday, April 19, 10:48-11:58 pm: Controversies in Anterior Segment Surgery: "Dropless Drug Delivery—Should We Be Transitioning to This Now?" - Eric D. Donnenfield, MD, San Diego Convention Center, Room 5A.
- Sunday, April 19, 3:00-4:30 pm: Cataract Dilemmas and Controversies: “Intracameral Antibiotics/Topical Versus Dropless Cataract Surgery (Safety and Cost/Efficiencies)” - David F. Chang, MD, Kent Stiverson, MD, and Robert J. Weinstock, MD, San Diego Convention Center, Room 6A.
- Monday, April 20, 1:00-2:30 pm: Course 20-305: "Dropless Cataract Surgery: Transzonular Placement of Antibiotic and Steroid for Postoperative Prophylaxis after Cataract Surgery" - M. Stewart Galloway, MD, James S. Lewis, MD, Jeffrey T. Liegner, MD, Richard Lindstrom, MD, and Ahad Mahootchi, MD, San Diego Convention Center, Room 6F.
- Monday, April 20, 3:00-4:35 pm: Cataract Medications: “Cystoid Macular Edema Rates with Intravitreal Transzonular Antibiotic/Steroid Prophylaxis,” - M. Stewart Galloway, MD and Jeffrey T. Liegner, MD, San Diego Convention Center, Room 1B.
Both Dropless Therapy and our Combination Drop Therapy will be discussed during Dr. Robert H. Osher’s annual “New Technologies” symposium:
- Monday, April 20, 3:00-4:30 pm: Symposium: “New Technologies – What Do I Really Need?” - Robert H. Osher, MD, San Diego Convention Center, Room 6A.
In addition, ASCRS will hold a 2015 FDA Symposium, Current FDA Issues: Update on Drug Compounding and the 21st Century Cures Initiative, consisting of two panels: a panel focusing on the drug compounding issue and its impact on ophthalmology which will include Mark L. Baum and a second panel highlighting the 21st Century Cures Initiative with a particular focus on the steps that can be taken to ensure that the drug and device approval process is fostering innovation in America. The FDA Symposium will take place on Sunday, April 19 from 8:00-9:30 am, San Diego Convention Center, Room 6D.
Additional information about Imprimis and its patent-pending, innovative treatment options and the events at ASCRS will be available to conference attendees at the Imprimis Booth #414.
Interested parties may register to attend the Go Dropless and LessDrops open house informational reception by visiting http://www.imprimispharma.com/ascrs2015.